| av node cell to bundle of his cell communication | GO:0086067 | 2 | 0.884 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.777 | |
| ascending aorta morphogenesis | GO:0035910 | 3 | 0.712 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.523 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.472 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.466 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.440 | |
| negative regulation of photoreceptor cell differentiation | GO:0046533 | 4 | 0.425 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.422 | |
| wound healing | GO:0042060 | 157 | 0.422 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.418 | |
| renal vesicle induction | GO:0072034 | 3 | 0.416 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.405 | |
| septum primum development | GO:0003284 | 4 | 0.399 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.397 | |
| tissue migration | GO:0090130 | 68 | 0.395 | |
| amine metabolic process | GO:0009308 | 45 | 0.392 | |
| ascending aorta development | GO:0035905 | 3 | 0.383 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.383 | |
| cardiac chamber development | GO:0003205 | 108 | 0.379 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.368 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.347 | |
| angiogenesis | GO:0001525 | 201 | 0.345 | |
| mitral valve development | GO:0003174 | 4 | 0.344 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.344 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.341 | |
| ear morphogenesis | GO:0042471 | 118 | 0.335 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.332 | |
| epithelial cell proliferation involved in prostatic bud elongation | GO:0060517 | 1 | 0.331 | |
| detection of mechanical stimulus involved in equilibrioception | GO:0050973 | 2 | 0.314 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.314 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.303 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.303 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.298 | |
| positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:0035793 | 1 | 0.296 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.294 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.291 | |
| stem cell fate specification | GO:0048866 | 3 | 0.291 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.289 | |
| male germ line sex determination | GO:0019100 | 2 | 0.286 | |
| regulation of vasculogenesis | GO:2001212 | 9 | 0.285 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.284 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.282 | |
| regulation of endothelial cell migration | GO:0010594 | 22 | 0.273 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.273 | |
| cell migration involved in kidney development | GO:0035787 | 3 | 0.270 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.261 | |
| epithelial cell migration | GO:0010631 | 63 | 0.260 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.259 | |
| gtp metabolic process | GO:0046039 | 144 | 0.257 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.257 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.257 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.253 | |
| ureter morphogenesis | GO:0072197 | 4 | 0.250 | |
| camera type eye development | GO:0043010 | 266 | 0.245 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.241 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.236 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.234 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.229 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.229 | |
| developmental maturation | GO:0021700 | 193 | 0.226 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.224 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.222 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.217 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.216 | |
| negative regulation of mesodermal cell fate specification | GO:0042662 | 3 | 0.216 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.211 | |
| artery development | GO:0060840 | 53 | 0.204 | |
| renal system development | GO:0072001 | 225 | 0.201 | |
| regulation of cell activation | GO:0050865 | 289 | 0.200 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.197 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.191 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.188 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.187 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.187 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.187 | |
| positive regulation of lens epithelial cell proliferation | GO:2001111 | 1 | 0.187 | |
| intrahepatic bile duct development | GO:0035622 | 2 | 0.186 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.184 | |
| regulation of cell migration | GO:0030334 | 219 | 0.182 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.182 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.181 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.180 | |
| cellular response to stem cell factor stimulus | GO:0036216 | 3 | 0.177 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.177 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.174 | |
| glucose homeostasis | GO:0042593 | 128 | 0.170 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.170 | |
| regulation of secretion | GO:0051046 | 274 | 0.166 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.166 | |
| epithelium migration | GO:0090132 | 63 | 0.164 | |
| pigment cell differentiation | GO:0050931 | 27 | 0.162 | |
| metanephric nephron epithelium development | GO:0072243 | 19 | 0.160 | |
| cerebral cortex development | GO:0021987 | 86 | 0.159 | |
| sensory perception of sound | GO:0007605 | 97 | 0.159 | |
| cardiac atrium development | GO:0003230 | 24 | 0.156 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.149 | |
| positive regulation of metanephric mesenchymal cell migration | GO:2000591 | 1 | 0.147 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.147 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.147 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.147 | |
| cell adhesion | GO:0007155 | 329 | 0.145 | Mouse |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.142 | |
| regulation of epithelial cell migration | GO:0010632 | 35 | 0.140 | |
| inner cell mass cellular morphogenesis | GO:0001828 | 1 | 0.140 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.139 | |
| endocardium formation | GO:0060214 | 4 | 0.139 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.139 | |
| cellular homeostasis | GO:0019725 | 240 | 0.138 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.137 | |
| regulation of lens epithelial cell proliferation | GO:2001109 | 1 | 0.137 | |
| endodermal cell fate determination | GO:0007493 | 2 | 0.136 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.133 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.132 | |
| camera type eye photoreceptor cell differentiation | GO:0060219 | 15 | 0.131 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.129 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.128 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.128 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.127 | |
| detection of stimulus | GO:0051606 | 84 | 0.127 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.126 | |
| male gamete generation | GO:0048232 | 285 | 0.126 | Mouse |
| cochlea development | GO:0090102 | 35 | 0.124 | |
| gall bladder development | GO:0061010 | 2 | 0.123 | |
| brain morphogenesis | GO:0048854 | 32 | 0.123 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.123 | |
| organ growth | GO:0035265 | 117 | 0.122 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.121 | |
| telencephalon development | GO:0021537 | 186 | 0.120 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.119 | |
| cytokine production | GO:0001816 | 319 | 0.119 | |
| nephron development | GO:0072006 | 109 | 0.119 | |
| metanephros morphogenesis | GO:0003338 | 24 | 0.117 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.117 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.117 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.117 | |
| skin development | GO:0043588 | 220 | 0.116 | Mouse |
| cell migration involved in coronary angiogenesis | GO:0060981 | 1 | 0.116 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.115 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.115 | |
| ventricular septum development | GO:0003281 | 42 | 0.115 | |
| regulation of branching involved in ureteric bud morphogenesis | GO:0090189 | 22 | 0.114 | |
| regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway | GO:1900238 | 1 | 0.114 | |
| connective tissue development | GO:0061448 | 179 | 0.114 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.114 | |
| endothelial cell migration | GO:0043542 | 44 | 0.114 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.113 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.113 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.112 | |
| heart morphogenesis | GO:0003007 | 178 | 0.112 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.111 | |
| endocardial cell differentiation | GO:0060956 | 4 | 0.111 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.111 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.110 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.110 | |
| metanephric nephron development | GO:0072210 | 34 | 0.110 | |
| negative regulation of canonical wnt signaling pathway | GO:0090090 | 51 | 0.109 | |
| spinal cord development | GO:0021510 | 81 | 0.109 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.108 | |
| cellular glucose homeostasis | GO:0001678 | 52 | 0.108 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.107 | |
| forebrain morphogenesis | GO:0048853 | 17 | 0.107 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.107 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.106 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.105 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.104 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.104 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.104 | |
| kidney epithelium development | GO:0072073 | 121 | 0.104 | |
| circulatory system process | GO:0003013 | 197 | 0.102 | |
| prostate gland morphogenetic growth | GO:0060737 | 4 | 0.102 | |
| epidermis development | GO:0008544 | 187 | 0.102 | |
| fat cell differentiation | GO:0045444 | 160 | 0.101 | |
| positive regulation of extracellular matrix organization | GO:1903055 | 4 | 0.101 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.100 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.098 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.098 | |
| ureter urothelium development | GO:0072190 | 3 | 0.097 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.097 | |
| ureteric bud development | GO:0001657 | 94 | 0.097 | |
| stem cell development | GO:0048864 | 219 | 0.097 | |
| forebrain development | GO:0030900 | 302 | 0.097 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.096 | |
| lung smooth muscle development | GO:0061145 | 2 | 0.096 | |
| blastocyst development | GO:0001824 | 80 | 0.095 | |
| g0 to g1 transition | GO:0045023 | 3 | 0.095 | |
| regulation of phosphatidylinositol 3 kinase activity | GO:0043551 | 14 | 0.095 | |
| cardiac atrium morphogenesis | GO:0003209 | 23 | 0.095 | |
| mapk cascade | GO:0000165 | 281 | 0.094 | |
| notch signaling pathway | GO:0007219 | 71 | 0.094 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.094 | |
| regulation of mesoderm development | GO:2000380 | 12 | 0.093 | |
| germ line sex determination | GO:0018992 | 3 | 0.093 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.092 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.091 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.091 | |
| tissue homeostasis | GO:0001894 | 115 | 0.091 | |
| cell junction organization | GO:0034330 | 77 | 0.091 | Mouse |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.091 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.090 | |
| liver development | GO:0001889 | 66 | 0.090 | |
| cardiac cell fate commitment | GO:0060911 | 10 | 0.089 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.089 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.088 | |
| regulation of auditory receptor cell differentiation | GO:0045607 | 4 | 0.088 | |
| detection of external stimulus | GO:0009581 | 61 | 0.088 | |
| t cell activation | GO:0042110 | 289 | 0.088 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.087 | |
| positive regulation of kidney development | GO:0090184 | 28 | 0.087 | |
| regulation of metanephric mesenchymal cell migration | GO:2000589 | 2 | 0.087 | |
| blastocyst formation | GO:0001825 | 33 | 0.087 | |
| gtp catabolic process | GO:0006184 | 143 | 0.086 | |
| immune effector process | GO:0002252 | 321 | 0.085 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.085 | |
| cardiogenic plate morphogenesis | GO:0003142 | 1 | 0.085 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.085 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.085 | |
| sensory perception | GO:0007600 | 245 | 0.084 | |
| closure of optic fissure | GO:0061386 | 2 | 0.084 | |
| kidney development | GO:0001822 | 213 | 0.084 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.084 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.083 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.083 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.083 | |
| renal system process | GO:0003014 | 48 | 0.083 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.083 | |
| gliogenesis | GO:0042063 | 141 | 0.082 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.082 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.082 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.082 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.082 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.081 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.081 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 41 | 0.080 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.080 | |
| regulation of extracellular matrix assembly | GO:1901201 | 2 | 0.080 | |
| atrial septum primum morphogenesis | GO:0003289 | 3 | 0.079 | |
| cell fate commitment | GO:0045165 | 210 | 0.079 | |
| positive regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014718 | 2 | 0.079 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.079 | |
| negative regulation of platelet derived growth factor receptor signaling pathway | GO:0010642 | 7 | 0.079 | |
| protein catabolic process | GO:0030163 | 221 | 0.078 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.078 | |
| endodermal digestive tract morphogenesis | GO:0061031 | 4 | 0.078 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.078 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.078 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.078 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.078 | |
| negative regulation of endothelial cell apoptotic process | GO:2000352 | 7 | 0.078 | |
| inner cell mass cell differentiation | GO:0001826 | 7 | 0.077 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.077 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.076 | |
| metanephric tubule development | GO:0072170 | 18 | 0.076 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.076 | |
| response to erythropoietin | GO:0036017 | 1 | 0.076 | |
| negative regulation of blood vessel endothelial cell migration | GO:0043537 | 3 | 0.076 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.075 | |
| lung alveolus development | GO:0048286 | 45 | 0.075 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.075 | |
| developmental cell growth | GO:0048588 | 84 | 0.074 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.074 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.074 | |
| urogenital system development | GO:0001655 | 261 | 0.073 | |
| olfactory bulb interneuron development | GO:0021891 | 7 | 0.073 | |
| cellular response to heparin | GO:0071504 | 1 | 0.072 | |
| spermatid differentiation | GO:0048515 | 115 | 0.072 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.072 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.072 | |
| heart trabecula formation | GO:0060347 | 14 | 0.072 | |
| erythropoietin mediated signaling pathway | GO:0038162 | 1 | 0.072 | |
| cardiac septum development | GO:0003279 | 59 | 0.072 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.071 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.071 | |
| heart valve morphogenesis | GO:0003179 | 21 | 0.071 | |
| noradrenergic neuron differentiation | GO:0003357 | 6 | 0.071 | |
| heart valve development | GO:0003170 | 23 | 0.071 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.070 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.070 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.070 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.070 | |
| equilibrioception | GO:0050957 | 3 | 0.069 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.069 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.069 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.069 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 30 | 0.069 | |
| diencephalon development | GO:0021536 | 63 | 0.069 | |
| chondrocyte hypertrophy | GO:0003415 | 4 | 0.069 | |
| positive regulation of g0 to g1 transition | GO:0070318 | 2 | 0.068 | |
| inner ear receptor cell differentiation | GO:0060113 | 61 | 0.068 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.067 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.067 | |
| neuromuscular process controlling balance | GO:0050885 | 59 | 0.066 | |
| muscle fiber development | GO:0048747 | 76 | 0.066 | |
| rac protein signal transduction | GO:0016601 | 13 | 0.066 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.066 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.066 | |
| nephron epithelium development | GO:0072009 | 92 | 0.065 | |
| cell migration involved in gastrulation | GO:0042074 | 13 | 0.065 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.065 | |
| lung development | GO:0030324 | 164 | 0.065 | |
| ear development | GO:0043583 | 200 | 0.064 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.064 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.064 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.064 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.064 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.064 | |
| gland development | GO:0048732 | 330 | 0.064 | |
| pallium development | GO:0021543 | 120 | 0.063 | |
| smooth muscle cell chemotaxis | GO:0071670 | 2 | 0.063 | |
| positive regulation of hippo signaling | GO:0035332 | 1 | 0.063 | |
| endothelial cell differentiation | GO:0045446 | 41 | 0.063 | Zebrafish |
| endothelium development | GO:0003158 | 45 | 0.063 | Zebrafish |
| leukocyte differentiation | GO:0002521 | 342 | 0.063 | |
| muscle tissue development | GO:0060537 | 308 | 0.063 | |
| negative regulation of myoblast differentiation | GO:0045662 | 18 | 0.063 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.063 | |
| regulation of wound healing | GO:0061041 | 40 | 0.063 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.062 | |
| response to acid chemical | GO:0001101 | 111 | 0.062 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.062 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.062 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.062 | |
| neural tube patterning | GO:0021532 | 43 | 0.062 | |
| regulation of cell proliferation involved in tissue homeostasis | GO:0060784 | 1 | 0.062 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.061 | |
| t cell differentiation | GO:0030217 | 174 | 0.061 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.061 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.061 | |
| digestion | GO:0007586 | 40 | 0.061 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.061 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.060 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.060 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.060 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.059 | |
| regulation of cell motility | GO:2000145 | 236 | 0.059 | |
| regulation of protein stability | GO:0031647 | 52 | 0.059 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.059 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.058 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.058 | |
| vascular endothelial growth factor receptor signaling pathway | GO:0048010 | 24 | 0.058 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.058 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.058 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.057 | |
| bronchus cartilage development | GO:0060532 | 2 | 0.057 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.057 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.057 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.056 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.056 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.056 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.056 | |
| hair cell differentiation | GO:0035315 | 40 | 0.056 | |
| regulation of stem cell division | GO:2000035 | 4 | 0.056 | |
| positive regulation of skeletal muscle tissue regeneration | GO:0043415 | 4 | 0.056 | |
| neural crest cell development | GO:0014032 | 48 | 0.056 | |
| axonogenesis | GO:0007409 | 274 | 0.056 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.055 | |
| trachea development | GO:0060438 | 18 | 0.055 | |
| metanephric nephron morphogenesis | GO:0072273 | 19 | 0.055 | |
| metanephric nephron tubule development | GO:0072234 | 16 | 0.055 | |
| blood circulation | GO:0008015 | 195 | 0.055 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.055 | |
| neural retina development | GO:0003407 | 41 | 0.054 | |
| glial cell differentiation | GO:0010001 | 131 | 0.054 | |
| regulation of cell division | GO:0051302 | 76 | 0.054 | |
| b cell activation | GO:0042113 | 161 | 0.054 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.054 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.054 | |
| detection of mechanical stimulus involved in sensory perception of sound | GO:0050910 | 16 | 0.054 | |
| muscle cell development | GO:0055001 | 133 | 0.054 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.054 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.054 | |
| hematopoietic stem cell proliferation | GO:0071425 | 13 | 0.053 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.053 | |
| kidney vasculature development | GO:0061440 | 15 | 0.053 | |
| neuronal action potential | GO:0019228 | 54 | 0.053 | Mouse |
| regulation of vasculature development | GO:1901342 | 88 | 0.053 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.053 | |
| cell division | GO:0051301 | 120 | 0.053 | |
| metanephros development | GO:0001656 | 79 | 0.052 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.052 | |
| spermatogenesis | GO:0007283 | 284 | 0.052 | Mouse |
| skeletal system development | GO:0001501 | 356 | 0.052 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.052 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.052 | |
| limb bud formation | GO:0060174 | 10 | 0.052 | |
| positive regulation of canonical wnt signaling pathway | GO:0090263 | 29 | 0.052 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.051 | |
| chemotaxis | GO:0006935 | 247 | 0.051 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.051 | |
| cartilage development | GO:0051216 | 140 | 0.051 | |
| negative regulation of vasculature development | GO:1901343 | 26 | 0.051 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.051 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.051 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.051 | |
| atrial septum development | GO:0003283 | 12 | 0.051 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.050 | |
| epithelial structure maintenance | GO:0010669 | 9 | 0.050 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.050 | |
| cellular response to lipid | GO:0071396 | 145 | 0.050 | |
| insulin secretion | GO:0030073 | 89 | 0.050 | |
| cell migration involved in sprouting angiogenesis | GO:0002042 | 9 | 0.050 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.050 | |
| embryonic placenta development | GO:0001892 | 98 | 0.050 | |
| positive regulation of mesonephros development | GO:0061213 | 20 | 0.050 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.050 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.050 | |
| cellular response to monosaccharide stimulus | GO:0071326 | 47 | 0.049 | |
| cell maturation | GO:0048469 | 127 | 0.049 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.049 | |
| digestive tract development | GO:0048565 | 190 | 0.049 | |
| multicellular organism growth | GO:0035264 | 161 | 0.049 | |
| cell fate determination | GO:0001709 | 32 | 0.049 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.049 | |
| skeletal muscle tissue regeneration | GO:0043403 | 20 | 0.049 | |
| platelet derived growth factor receptor beta signaling pathway | GO:0035791 | 4 | 0.049 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.048 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.048 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.048 | |
| tube formation | GO:0035148 | 140 | 0.048 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.048 | |
| cellular response to epidermal growth factor stimulus | GO:0071364 | 4 | 0.048 | |
| stem cell differentiation | GO:0048863 | 268 | 0.048 | |
| hormone metabolic process | GO:0042445 | 86 | 0.048 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.047 | |
| prostate gland morphogenesis | GO:0060512 | 32 | 0.047 | |
| glomerular mesangial cell differentiation | GO:0072008 | 3 | 0.047 | |
| vasodilation | GO:0042311 | 28 | 0.047 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.047 | |
| rhythmic process | GO:0048511 | 174 | 0.047 | |
| regulation of kidney development | GO:0090183 | 40 | 0.047 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.047 | |
| mesoderm development | GO:0007498 | 100 | 0.046 | |
| limbic system development | GO:0021761 | 72 | 0.046 | |
| angiogenesis involved in coronary vascular morphogenesis | GO:0060978 | 2 | 0.046 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.046 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.046 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.046 | |
| epithelial cell proliferation involved in prostate gland development | GO:0060767 | 11 | 0.046 | |
| nephron tubule formation | GO:0072079 | 20 | 0.046 | |
| neuron migration | GO:0001764 | 122 | 0.045 | |
| mesenchyme development | GO:0060485 | 152 | 0.045 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.045 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.045 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.045 | |
| cellular response to hexose stimulus | GO:0071331 | 47 | 0.045 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.045 | |
| soft palate development | GO:0060023 | 2 | 0.045 | |
| nephron tubule development | GO:0072080 | 84 | 0.045 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.044 | |
| limb development | GO:0060173 | 166 | 0.044 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.044 | |
| adenohypophysis development | GO:0021984 | 14 | 0.044 | |
| male sex differentiation | GO:0046661 | 109 | 0.044 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.044 | |
| bone mineralization | GO:0030282 | 54 | 0.044 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.044 | |
| lung morphogenesis | GO:0060425 | 50 | 0.044 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.044 | |
| response to heparin | GO:0071503 | 1 | 0.043 | |
| endocardial cushion morphogenesis | GO:0003203 | 18 | 0.043 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.043 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.043 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.043 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.043 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.043 | |
| epithelial tube formation | GO:0072175 | 130 | 0.043 | |
| adipose tissue development | GO:0060612 | 25 | 0.043 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.043 | |
| cellular response to glucose stimulus | GO:0071333 | 45 | 0.043 | |
| response to monosaccharide | GO:0034284 | 67 | 0.042 | |
| positive regulation of neuroblast proliferation | GO:0002052 | 19 | 0.042 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.042 | |
| sympathetic neuron projection extension | GO:0097490 | 4 | 0.042 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.042 | |
| mechanoreceptor differentiation | GO:0042490 | 67 | 0.042 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.042 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.042 | |
| glomerular mesangial cell development | GO:0072144 | 3 | 0.042 | |
| cell migration involved in endocardial cushion formation | GO:0003273 | 3 | 0.042 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.041 | |
| endocardium development | GO:0003157 | 10 | 0.041 | |
| metanephric tubule formation | GO:0072174 | 6 | 0.041 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.041 | |
| developmental induction | GO:0031128 | 34 | 0.041 | |
| sertoli cell differentiation | GO:0060008 | 18 | 0.041 | |
| leukocyte migration | GO:0050900 | 124 | 0.041 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.041 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.041 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.041 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.040 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.040 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.040 | |
| negative regulation of mesoderm development | GO:2000381 | 8 | 0.040 | |
| positive regulation of branching involved in ureteric bud morphogenesis | GO:0090190 | 18 | 0.040 | |
| negative regulation of cartilage development | GO:0061037 | 17 | 0.039 | |
| sympathetic nervous system development | GO:0048485 | 22 | 0.039 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.039 | |
| regulation of endothelial cell proliferation | GO:0001936 | 23 | 0.039 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.039 | |
| endochondral bone morphogenesis | GO:0060350 | 50 | 0.039 | |
